Skip to main content
SpringerLink
Log in

Serum but not salivary cortisol levels are influenced by daily glycemic oscillations in type 2 diabetes

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Diurnal salivary and plasma cortisol variations are considered valid expression of circadian cortisol rhythmicity. The aim of this study was to assess the reliability of salivary and plasma cortisol and if glycemia and glycemic oscillations may interfere with their concentration. Forty-seven type 2 diabetic patients and 31 controls were studied for glycemic profile and diurnal salivary and plasma cortisol variations on two contemporary samples taken at 08:00 a.m.–11:00 p.m (Late Night, LN). Glucose variability was evaluated in diabetic patients by considering the standard deviation of blood glucose (BGSD) readings, by calculating the mean amplitude of glycemic excursions (MAGEs) and continuous overlapping net glycemic action (CONGA). A significant correlation between LN serum cortisol and morning fasting glycemia (r = 0.78; p = 0.004) was observed in T2DM group but not in the control group (r = 0.09; p = 0.74). While LN serum cortisol significantly correlated with CONGA in diabetic patients (r = 0.50; p < 0.001), LN salivary cortisol did not correlate with any indices of glucose variability. Moreover, a highly significant correlation between LN salivary and LN serum cortisol concentrations was found in control group (r = 0.80; p < 0.001) but not in diabetic patients (r = 0.07; p = 0.62). This study shows for the first time that LN salivary rather than plasma cortisol may give information on the dynamics of adrenal function of type 2 diabetic patients, as it is not significantly influenced by glycemic variations. However, our preliminary results need to be confirmed by further studies with more complete evaluations including many more patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. G. Mazziotti, C. Gazzaruso, A. Giustina, Diabetes in Cushing syndrome: basic and clinical aspects. Trends Endocrinol. Metab. 22, 499–506 (2011)

    Article  CAS  PubMed  Google Scholar 

  2. K. Esposito, G. Bellastella, M.I. Maiorino, R. Pivonello, A. Colao, D. Giugliano, Cushing syndrome, metabolic syndrome and inflammation: a suggested way out. Rev. Endocrinol. Metab. 1, 41–45 (2013)

    Google Scholar 

  3. T. Krarup, T. Krarup, C. Hagen, Do patients with type 2 diabetes mellitus have an increased prevalence of Cushing’s syndrome? Diabetes Metab. Res. Rev. 28, 219–227 (2012)

    Article  CAS  PubMed  Google Scholar 

  4. B. Catargi, V. Rigalleau, A. Poussin, N. Ronci-Chaix, V. Bex, V. Vergnot, H. Gin, P. Roger, A. Tabarin, Occult Cushing’s syndrome in type-2 diabetes. J. Clin. Endocrinol. Metab. 88, 5808–5813 (2003)

    Article  CAS  PubMed  Google Scholar 

  5. G. Reimondo, A. Pia, B. Allasino, F. Tassone, S. Bovio, G. Borretta, A. Angeli, M. Terzolo, Screening of Cushing’s syndrome in adult patients with newly diagnosed diabetes mellitus. Clin. Endocrinol. (Oxf) 67, 225–229 (2007)

    Article  CAS  Google Scholar 

  6. I. Chiodini, M. Torlontano, A. Scillitani, M. Arosio, S. Bacci, S. Di Lembo, P. Epaminonda, G. Augello, R. Enrini, B. Ambrosi, G. Adda, V. Trischitta, Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. Eur. J. Endocrinol. 153, 837–844 (2005)

    Article  CAS  PubMed  Google Scholar 

  7. A. Gungunes, M. Sahin, T. Demirci, B. Ucan, E. Cakir, M.S. Arslan, I.O. Unsal, B. Karbek, M. Calıskan, M. Ozbek, E. Cakal, T. Delibasi, Cushing’s syndrome in type 2 diabetes patients with poor glycemic control. Endocrine 47, 895–900 (2014)

    Article  CAS  PubMed  Google Scholar 

  8. S. Newsome, K. Chen, J. Hoang, J.D. Wilson, J.M. Potter, P.E. Hickman, Cushing’s syndrome in a clinic population with diabetes. Intern. Med. J. 38, 178–182 (2008)

    Article  CAS  PubMed  Google Scholar 

  9. H. Raff, J.L. Raff, J.W. Findling, Late-night salivary cortisol as a screening test for Cushing’s syndrome. J. Clin. Endocrinol. Metab. 83, 2681–2686 (1998)

    CAS  PubMed  Google Scholar 

  10. M. Trilck, J. Flitsch, D.K. Lüdecke, R. Jung, S. Petersenn, Salivary cortisol measurement–a reliable method for the diagnosis of Cushing’s syndrome. Exp. Clin. Endocrinol. Diabetes 113, 225–230 (2005)

    Article  CAS  PubMed  Google Scholar 

  11. H. Raff, Update on late-night salivary cortisol for the diagnosis of Cushing’s syndrome: methodological considerations. Endocrine 44(2), 346–349 (2013). doi:10.1007/s12020-013-0013-0

    Article  CAS  PubMed  Google Scholar 

  12. V. Bansal, N. El Asmar, W.R. Selman, B.M. Arafah, Pitfalls in the diagnosis and management of Cushing’s syndrome. Neurosurg. Focus 38, E4 (2015)

    Article  PubMed  Google Scholar 

  13. G. Arnaldi, A. Angeli, A.B. Atkinson, X. Bertagna, F. Cavagnini, G.P. Chrousos, G.A. Fava, J.W. Findling, R.C. Gaillard, A.B. Grossman, B. Kola, A. Lacroix, T. Mancini, F. Mantero, J. Newell-Price, L.K. Nieman, N. Sonino, M.L. Vance, A. Giustina, M. Boscaro, Diagnosis and complications of Cushing’s syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 88, 5593–5602 (2003)

    Article  CAS  PubMed  Google Scholar 

  14. L.K. Nieman, B.M. Biller, J.W. Findling, J. Newell-Price, M.O. Savage, P.M. Stewart, V.M. Montori, The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 93, 1526–1540 (2008)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. E.M. Poll, I. Kreitschmann-Andermahr, Y. Langejuergen, S. Stanzel, J.M. Gilsbach, A. Gressner, E. Yagmur, Saliva collection method affects predictability of serum cortisol. Clin. Chim. Acta 382, 15–19 (2007)

    Article  CAS  PubMed  Google Scholar 

  16. L.D. Dorn, J.F. Lucke, T.L. Loucks, S.L. Berga, Salivary cortisol reflects serum cortisol: analysis of circadian profiles. Ann. Clin. Biochem. 44, 281–284 (2007)

    Article  CAS  PubMed  Google Scholar 

  17. M.S. Karpman, M. Neculau, V.C. Dias, G.A. Kline, Defining adrenal status with salivary cortisol by gold-standard insulin hypoglycemia. Clin. Biochem. 46, 1442–1446 (2013)

    Article  CAS  PubMed  Google Scholar 

  18. E.O. Melin, M. Thunander, M. Landin-Olsson, M. Hillman, H.O. Thulesius, Depression, smoking, physical inactivity and season independently associated with midnight salivary cortisol in type 1 diabetes. BMC Endocr. Disord. 14, 75 (2014)

    Article  PubMed  PubMed Central  Google Scholar 

  19. R.A. Hackett, A. Steptoe, M. Kumari, Association of diurnal patterns in salivary cortisol with type 2 diabetes in the Whitehall II study. J. Clin. Endocrinol. Metab. 99, 4625–4631 (2014)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. J. Newell-Price, P. Trainer, L. Perry, J. Wass, A. Grossman, M. Besser, A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing’s syndrome. Clin Endocrinol (Oxf) 43, 545–550 (1995)

    Article  CAS  Google Scholar 

  21. H.M. Kronenberg, S. Melmed, K.S. Polonsky, P. Reed Larsen, Williams Textbook of Endocrinology, 11th edn. (Elsevier, Saunders, 2007). ISBN 1416029117

    Google Scholar 

  22. N.R. Hill, N.S. Oliver, P. Choudhary, J.C. Levy, P. Hindmarsh, D.R. Matthews, Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. Diabetes Technol. Ther. 13, 921–928 (2011)

    Article  PubMed  PubMed Central  Google Scholar 

  23. F. Picconi, A. Di Flaviani, I. Malandrucco, I. Giordani, S. Frontoni, Impact of glycemic variability on cardiovascular outcomes beyond glycated hemoglobin. Evidence and clinical perspectives. Nutr. Metab. Cardiovasc. Dis. 22, 691–696 (2012)

    Article  CAS  PubMed  Google Scholar 

  24. J. Smith-Palmer, M. Brändle, R. Trevisan, M. Orsini, S. Federici, L.W. Valentine, Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes. Diabetes Res. Clin. Pract. 105, 273–284 (2014)

    Article  CAS  PubMed  Google Scholar 

  25. C.M. McDonnell, S.M. Donath, S.I. Vidmar, G.A. Werther, F.J. Cameron, A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol. Ther. 7, 253–263 (2005)

    Article  CAS  PubMed  Google Scholar 

  26. E. Standl, O. Schnell, A. Ceriello, Postprandial hyperglycemia and glycemic variability: should we care? Diabetes Care 34, S120–S127 (2011)

    Article  PubMed  PubMed Central  Google Scholar 

  27. M. Stolar, Glycemic control and complications in type 2 diabetes mellitus. Am. J. Med. 123, S3–S11 (2010)

    Article  CAS  PubMed  Google Scholar 

  28. Y. Liu, Y. He, Effect of blood glucose excursions on the risk of diabetic retinopathy in type 2 diabetes. In: 2011 Diabetes Conference: 71st scientific sessions of the American Diabetes Association, San Diego (Abstract) (2011)

  29. M. Barbieri, M.R. Rizzo, R. Marfella, V. Boccardi, A. Esposito, A. Pansini, G. Paolisso, Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors. Atherosclerosis 227, 349–354 (2013)

    Article  CAS  PubMed  Google Scholar 

  30. I. Chiodini, G. Adda, A. Scillitani, F. Coletti, V. Morelli, S. Di Lembo, P. Epaminonda, B. Masserini, P. Beck-Peccoz, E. Orsi, B. Ambrosi, M. Arosio, Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications. Diabetes Care 30, 83–88 (2007)

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrinology and Metabolic Diseases Unit, Department of Medical, Surgical, Neurological, Metabolic and Geriatric Sciences, Second University of Naples, Piazza L. Miraglia 2, 80138, Naples, Italy

    Giuseppe Bellastella, Maria Ida Maiorino, Carmela Mosca, Lorenzo Scappaticcio & Dario Giugliano

  2. Endocrinology and Metabolic Diseases Unit, Department of Cardiothoracic and Respiratory Sciences, Second University of Naples, Naples, Italy

    Annamaria De Bellis & Daniela Pasquali

  3. Department of Biochemistry, Biophysics and General Pathology, Second University of Naples, Naples, Italy

    Maria Teresa Vietri

  4. Diabetes Unit, Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy

    Katherine Esposito

Authors
  1. Giuseppe Bellastella
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Ida Maiorino
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Annamaria De Bellis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria Teresa Vietri
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Carmela Mosca
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lorenzo Scappaticcio
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Daniela Pasquali
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Katherine Esposito
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Dario Giugliano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giuseppe Bellastella.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bellastella, G., Maiorino, M.I., De Bellis, A. et al. Serum but not salivary cortisol levels are influenced by daily glycemic oscillations in type 2 diabetes. Endocrine 53, 220–226 (2016). https://doi.org/10.1007/s12020-015-0777-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-015-0777-5

Keywords

Search

Navigation